Cisplatin Resistance in an Ovarian Carcinoma Is Associated With a Defect in Programmed Cell Death Control Through XIAP Regulation
Oncology Research - United States
doi 10.3727/096504003108748410
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2003
Authors
Publisher
Cognizant, LLC